PNA-DNA oligomers and methods of use thereof
First Claim
1. A PNA-DNA oligomer comprising:
- a peptide nucleic acid (PNA) oligomer and a deoxyribonucleic acid (DNA) oligomer, wherein the PNA oligomer and DNA oligomer are covalently linked by a C6 amino linker having the formula;
1 Assignment
0 Petitions
Accused Products
Abstract
Peptide nucleic acid (PNA)-deoxyribonucleic acid (DNA) oligomers and methods of using the PNA-DNA oligomers to detect and/or amplify a target nucleic acid in a sample are provided. The PNA-DNA oligomers of the invention are relatively insensitive to ionic concentration and many inhibitory proteins and, consequently, are particularly advantageous for direct use in environmental or challenging samples to detect nucleic acid, especially that of microorganisms, including food and water pathogens and/or bioterrorism agents. Methods are also provided for use of the PNA-DNA oligomers in applications including polymerase chain reaction, nucleic acid sequencing, mutation detection and as nucleic acid probes.
19 Citations
37 Claims
-
1. A PNA-DNA oligomer comprising:
- a peptide nucleic acid (PNA) oligomer and a deoxyribonucleic acid (DNA) oligomer, wherein the PNA oligomer and DNA oligomer are covalently linked by a C6 amino linker having the formula;
- View Dependent Claims (2)
- a peptide nucleic acid (PNA) oligomer and a deoxyribonucleic acid (DNA) oligomer, wherein the PNA oligomer and DNA oligomer are covalently linked by a C6 amino linker having the formula;
-
3. A method for detecting the presence of a target nucleic acid in a sample comprising:
-
a) combining a peptide nucleic acid (PNA)-deoxyribonucleic acid (DNA) oligomer, a labeled probe, a DNA polymerase having exonuclease activity, unlabeled deoxyribonucleotide triphosphates (dNTPs) and said sample, thereby forming a combination; b) maintaining said combination under conditions suitable for extending said PNA-DNA oligomer in the presence of the target nucleic acid wherein; i) said PNA-DNA oligomer and labeled probed are annealed to said target nucleic acid and wherein said labeled probe anneals to the target nucleic acid downstream of the PNA-DNA oligomer; and ii) said DNA polymerase extends said PNA-DNA oligomer annealed to the target nucleic acid in the presence of the unlabeled deoxyribonucleotide triphosphates (dNTPs), thereby forming a full-length unlabeled nucleic acid product, wherein the exonuclease activity of the DNA polymerase degrades the labeled probe annealed to the target nucleic acid during extension of the PNA-DNA oligomer annealed to the target nucleic acid, thereby resulting in emission of a detectable signal; and c) analyzing said combination for emission of said detectable signal, wherein emission of the detectable signal indicates the presence of the target nucleic acid in the sample. - View Dependent Claims (4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
-
15. A method for detecting the presence of a target ribonucleic acid (RNA) in a sample comprising:
-
a) combining a first peptide nucleic acid (PNA)-deoxyribonucleic acid (DNA) oligomer, a reverse transcriptase enzyme, unlabeled deoxyribonucleotide phosphates (dNTPs) and said sample, thereby forming a first combination; b) maintaining said combination under conditions suitable for extending said first PNA-DNA oligomer in the presence of the target RNA wherein; i) said first PNA-DNA oligomer anneals to said target RNA in said sample; and ii) said reverse transcriptase enzyme extends said first PNA-DNA oligomer annealed to the target RNA in the presence of the unlabeled dNTPs, thereby forming a full-length unlabeled cDNA product; c) combining a second PNA-DNA oligomer, a labeled probe, a DNA polymerase having exonuclease activity and the full-length unlabeled cDNA product, thereby forming a second combination; d) maintaining said second combination under conditions suitable for extending said second PNA-DNA oligomer in the presence of the full-length unlabeled cDNA product wherein; i) said second PNA-DNA oligomer and labeled probed are annealed to the full-length unlabeled cDNA product and wherein said labeled probe anneals to the full-length unlabeled cDNA product downstream of the second PNA-DNA oligomer; and ii) said DNA polymerase extends said second PNA-DNA oligomer annealed to said full-length unlabeled cDNA product in the presence of the unlabeled dNTPs, thereby forming a full-length unlabeled DNA product, wherein the exonuclease activity of the DNA polymerase degrades the labeled probe annealed to the full-length unlabeled cDNA product during extension of the second PNA-DNA oligomer annealed to the full-length unlabeled cDNA product, thereby resulting in emission of a detectable signal; and e) analyzing said second combination for emission of said detectable signal, wherein emission of said detectable signal indicates the presence of said target RNA in the sample.
-
-
16. A method for detecting the presence of a target nucleic acid in a sample comprising:
-
a) combining a peptide nucleic acid (PNA)-deoxyribonucleic acid (DNA) oligomer, a DNA polymerase, unlabeled deoxyribonucleotide triphosphates (dNTPs), and said sample, thereby forming a combination; b) maintaining said combination under conditions suitable for extending said PNA-DNA oligomer in the presence of the target nucleic acid wherein; i) said PNA-DNA oligomer is annealed to said target nucleic acid; and ii) said DNA polymerase extends said PNA-DNA oligomer annealed to the target nucleic acid in the presence of the unlabeled dNTPs, thereby forming a full-length unlabeled target nucleic acid product; c) amplifying said full-length unlabeled target nucleic acid product comprising; i) denaturing the full-length unlabeled target nucleic acid product, ii) maintaining the PNA-DNA oligomer, the DNA polymerase, a reverse complementary primer and the denatured full-length unlabeled target nucleic acid product under conditions suitable for extending the PNA-DNA oligomer and said reverse complementary primer in the presence of the denatured full-length unlabeled target nucleic acid product, wherein the PNA-DNA oligomer and the reverse complementary primer anneal to the denatured full-length unlabeled target nucleic acid product and wherein the DNA polymerase extends the PNA-DNA oligomer and the reverse complementary primer annealed to the denatured full-length unlabeled target nucleic acid product in the presence of unlabeled dNTPs, thereby forming full-length unlabeled target nucleic acid product, and iii) repeating steps i) and ii) one or more times, thereby producing one or more full-length unlabeled target nucleic acid products; and d) detecting said one or more full-length unlabeled target nucleic acid products, wherein the presence of one or more full-length target nucleic acid products indicates the presence of said target nucleic acid in the sample. - View Dependent Claims (17)
-
-
18. A method of amplifying a target nucleic acid comprising:
-
a) combining a peptide nucleic acid (PNA)-deoxyribonucleic acid (DNA) oligomer, a reverse complementary primer, a labeled probe, a DNA polymerase having exonuclease activity, unlabeled deoxyribonucleotide triphosphates (dNTPs) and said target nucleic acid, thereby forming a combination; b) maintaining said combination under conditions suitable for extending said PNA-DNA oligomer in the presence of the target nucleic acid wherein; i) said PNA-DNA oligomer and labeled probed are annealed to said target nucleic acid and wherein said labeled probe anneals to the target nucleic acid downstream of the PNA-DNA oligomer; and ii) said DNA polymerase extends said PNA-DNA oligomer annealed to the target nucleic acid in the presence of the unlabeled dNTPs, thereby forming full-length unlabeled target nucleic acid product, wherein the exonuclease activity of the DNA polymerase degrades the labeled probe annealed to the target nucleic acid during extension of the PNA-DNA oligomer annealed to the target nucleic acid, thereby resulting in emission of a detectable signal; c) denaturing the full-length unlabeled target nucleic acid product and; d) repeating steps b) and c) one or more times, thereby forming one or more unlabeled target nucleic acid products and thereby amplifying the target nucleic acid. - View Dependent Claims (19, 20, 21, 22)
-
-
23. A method of amplifying a target nucleic acid comprising:
-
a) combining a peptide nucleic acid (PNA)-deoxyribonucleic acid (DNA) oligomer, a reverse complementary primer, a DNA polymerase, unlabeled deoxyribonucleotide triphosphates (dNTPs) and said target nucleic acid, thereby forming a combination; b) maintaining the PNA-DNA oligomer, the DNA polymerase, a reverse complementary primer and the target nucleic acid, under conditions suitable for extending the PNA-DNA oligomer and said reverse complementary primer in the presence of the target nucleic acid, wherein; i) the PNA-DNA oligomer and the reverse complementary primer anneal to the target nucleic acid, and ii) the DNA polymerase extends the PNA-DNA oligomer and the reverse complementary primer annealed to the target nucleic acid, in the presence of the unlabeled dNTPs, thereby forming full-length unlabeled target nucleic acid product; c) denaturing the full-length unlabeled target nucleic acid product; and d) repeating steps b) and c) one or more times, thereby forming one or more full-length unlabeled target nucleic acid products and thereby amplifying the target nucleic acid. - View Dependent Claims (24, 25, 26)
-
-
27. A method of probing a target nucleic acid comprising:
a) hybridizing to the target nucleic acid an unlabeled peptide nucleic acid (PNA)-deoxyribonucleic acid (DNA) oligomer comprising at least one PNA oligomer and at least one DNA oligomer, wherein the at least one PNA oligomer and at least one DNA oligomer are covalently linked by a linker selected from the group consisting of a C6 amino linker having the formula; - View Dependent Claims (28, 29, 30)
-
31. A method for designing a peptide nucleic acid (PNA)-deoxyribonucleic acid (DNA) oligomer that binds a target nucleic acid comprising:
-
a) obtaining the sequence of the target nucleic acid; and b) determining a complementary PNA-DNA oligomer sequence for a region on said target nucleic acid, thereby identifying a potential PNA-DNA oligomer, wherein the potential PNA-DNA oligomer is accepted or rejected in a method comprising; i) calculating the percent of guanine (G) and cytosine (C) nucleotides in the potential PNA-DNA oligomer, wherein if said percent of G and C nucleotides is between about 30% and about 80%, then the potential PNA-DNA oligomer is accepted; ii) calculating the melting temperature of the potential PNA-DNA oligomer, wherein if the melting temperature is between about 54°
C. and about 64°
C., then the potential PNA-DNA oligomer is accepted;iii) determining the number of contiguous adenine (A), contiguous thymine (T), contiguous guanine (G) and contiguous cytosine (C) nucleotides in the potential PNA-DNA oligomer, wherein if there are less than;
(a) four contiguous A nucleotides, (b) four contiguous T nucleotides, (c) three contiguous C nucleotides and (d) three contiguous G nucleotides, then the potential PNA-DNA oligomer is accepted;iv) calculating the percent of adenine (A) and guanine (G) nucleotides in the PNA oligomer portion of the potential PNA-DNA oligomer, thereby determining the purine content of the potential PNA-DNA oligomer, wherein if said percent of A and G nucleotides is less than or equal to about 60%, then the potential PNA-DNA oligomer is accepted; v) calculating the percent of guanine (G) and cytosine (C) nucleotides in the PNA oligomer portion of the potential PNA-DNA oligomer, wherein if said percent of G and C nucleotides is between about 30% and about 80%, then the potential PNA-DNA oligomer is accepted; vi) calculating the melting temperature of the PNA oligomer portion of the potential PNA-DNA oligomer, wherein if the melting temperature is between about 9°
C. and about 15°
C., then the potential PNA-DNA oligomer is accepted, andvii) determining the number of contiguous G and C nucleotides in the PNA oligomer portion of the potential PNA-DNA oligomer, wherein if there are not three contiguous G or three contiguous C nucleotides, then the PNA-DNA oligomer is accepted. - View Dependent Claims (32, 33, 34, 35)
-
-
36. A computer program product comprising a computer useable medium including a computer readable program, wherein the computer readable program, when executed on a computer causes the computer to:
-
a) obtain the sequence of the target nucleic acid; and b) determine a complementary peptide nucleic acid (PNA)-deoxyribonucleic acid (DNA) oligomer sequence for a region on said target nucleic acid, thereby identifying a potential PNA-DNA oligomer; c) calculate the percent of guanine (G) and cytosine (C) nucleotides in the potential PNA-DNA oligomer, wherein if said percent of G and C nucleotides is between about 30% and about 80%, then the computer accepts the potential PNA-DNA oligomer; d) calculate the melting temperature of the potential PNA-DNA oligomer, wherein if the melting temperature is between about 54°
C. and about 64°
C., then the computer accepts the potential PNA-DNA oligomer;e) determine the number of contiguous adenine (A), contiguous thymine (T), contiguous guanine (G) and contiguous cytosine (C) nucleotides in the potential PNA-DNA oligomer, wherein if there are less than;
(a) four contiguous A nucleotides, (b) four contiguous T nucleotides, (c) three contiguous C nucleotides and (d) three contiguous G nucleotides, then the computer accepts the potential PNA-DNA oligomer;f) calculate the percent of adenine (A) and guanine (G) nucleotides in the PNA oligomer portion of the potential PNA-DNA oligomer, thereby determining the purine content of the potential PNA-DNA oligomer, wherein if said percent of A and G nucleotides is less than or equal to about 60%, then the computer accepts the potential PNA-DNA oligomer; g) calculate the percent of guanine (G) and cytosine (C) nucleotides in the PNA oligomer portion of the potential PNA-DNA oligomer, wherein if said percent of G and C nucleotides is between about 30% and about 80%, then the computer accepts the potential PNA-DNA oligomer; h) calculate the melting temperature of the PNA oligomer portion of the potential PNA-DNA oligomer, wherein if the melting temperature is between about 9°
C. and about 15°
C., then the computer accepts the potential PNA-DNA oligomer; andi) determine the number of contiguous G and C nucleotides in the PNA oligomer portion of the potential PNA-DNA oligomer, wherein if there are not three contiguous G or three contiguous C nucleotides, then the computer accepts the potential PNA-DNA oligomer.
-
-
37. A computer program product comprising a computer useable medium including a computer readable program, wherein the computer readable program, when executed on a computer causes the computer to:
-
a) determine a probe-binding region on said target nucleic acid located between 1 and 5 nucleotides 3′
to the region a peptide nucleic acid (PNA)-deoxyribonucleic acid (DNA) oligomer binds a target nucleic acid;b) determine a complementary nucleotide sequence for said probe-binding region, thereby identifying a potential probe; c) calculate the percent of cytosine (C) and guanine (G) nucleotides in said potential probe, wherein if the percent of C and G nucleotides is between about 30% and about 80%, then the computer accepts the potential probe; d) calculate the melting temperature for said potential probe, wherein if the melting temperature is between about 65°
C. and about 85°
C. then the computer accepts the potential probe;e) determine the number of contiguous adenine (A), contiguous thymine (T), contiguous guanine (G) and contiguous cytosine (C) nucleotides in the potential probe, wherein if there are less than;
(a) four contiguous A nucleotides, (b) four contiguous T nucleotides, (c) three contiguous C nucleotides and (d) three contiguous G nucleotides, then the computer accepts the potential probe andf) identify the first nucleotide base of the potential probe, wherein if the first nucleotide base is an adenine (A), thymine (T) or a cytosine (C), then the computer accepts the potential probe.
-
Specification